#Baxalta (BXLT)

Baxalta (BXLT)   and Precision BioSciences a genome editing company announced a global collaboration to develop a broad series of  allogeneic chimeric antigen receptor (CAR) T  cell therapies directed...

The Biotechnology Sector It was, it has been will always be that a negative market performance is the chief inhibitor of the biotech sector. The biotechnology sector itself is continuing to reach revo...

The Biotechnology sector, which was recently hit by the market continues to excel and provide breakthroughs for diseases that had never been treated before. The number of 2015 drugs granted approval b...

Nektar/AstraZeneca Nektar is outperforming and it deserves it. Movantik (naloxegol) Nektar’s opioid-induced constipation drug, which is marketed by AstraZeneca handed Nectar $140 million in milestone...